Rationale: Insufficient world-wide clinical experience in radioiodine therapy (RIT) for Graves' disease (GD) in children and adolescents, and limited knowledge of the predictors of RIT efficacy.
Aims: Analysis and identification of the most significant predictors of the efficacy of RIT in children and adolescents with Graves' disease.
Materials And Methods: A total of 55 patients (48 females and 7 males) aged from 8 to 18 years receiving primary RIT for GD were enrolled.